Desensitization Therapy with Immunoglobulin (IVIG) and Rituximab for Patients Awaiting Heart Transplantation

被引：1
|
作者：
Patel, J. [1 ]
Kittleson, M. [1 ]
Rafiei, M. [1 ]
Stern, L. [1 ]
Chang, D. [1 ]
Czer, L. [1 ]
Trento, A. [1 ]
Kobashigawa, J. [1 ]
机构：
[1] Cedars Sinai Heart Inst, Los Angeles, CA USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2012年 / 31卷 / 04期
关键词：
D O I：
10.1016/j.healun.2012.01.468
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
457
引用
收藏
页码：S161 / S161
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of a Desensitization Treatment With Rituximab and Immunoglobulin in Hyperimmunized Patients Awaiting a Cadaveric Kidney Transplantation
    Garcia, Elena Gonzalez
    Oliva, Maria Lopez
    Mancebo, Esther
    Santana, Maria Jose
    Machado, Lina Maria Leon
    Fernandez, Cristina Fuentes
    Jimenez, Carlos
    TRANSPLANTATION PROCEEDINGS, 2025, 57 (01) : 3 - 6
  • [2] Use of IVIG plus single dose rituximab for desensitization of highly-HLA sensitized patients awaiting kidney transplantation
    Vo, Ashley A.
    Chang, Robert
    Toyoda, Mieko
    Reinsmoen, Nancy
    Peng, Alice
    Villicana, Rafael
    Jordan, Stanley C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 181 - 181
  • [3] Desensitization of highly HLA sensitized crossmatch (+) patients awaiting living donor (LD) kidney transplantation using IVIG plus Rituximab
    Vo, Ashley A.
    Chang, Robert
    Toyoda, Mieko
    Reinsmoen, Nancy
    Lukovsky, Marina
    Peng, Alice
    Villicana, Rafael
    Jordan, Stanley C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 353 - 353
  • [4] Sequential Dosing of Rituximab and IVIg for Desensitization of Highly-HLA Sensitized (HS) Patients Awaiting HLAi Kidney Transplantation.
    Vo, A. A.
    Huang, E.
    Williamsons, S.
    Myers, C.
    Peng, A.
    Najjar, R.
    Sethi, S.
    Lim, K.
    Ammerman, N.
    Gordan, S. C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 812 - 813
  • [5] Sex Differences in Desensitization for Patients Awaiting Heart Transplantation: Is There a Difference?
    Patel, J.
    Kittleson, M.
    Kransdorf, E.
    Singer-Englar, T.
    Patel, N.
    Yamamoto, N.
    Kim, S.
    Hamilton, M.
    Emerson, D.
    Czer, L.
    Kobashigawa, J. A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S202 - S202
  • [6] SEX DIFFERENCES IN DESENSITIZATION FOR PATIENTS AWAITING HEART TRANSPLANTATION: IS THERE A DIFFERENCE?
    Yamamoto, N.
    Patel, N.
    Singer-Englar, T.
    Kim, S.
    Hamilton, M.
    Kobashigawa, J.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (01) : 154 - 155
  • [7] Desensitization strategies in the patient awaiting heart transplantation
    Chang, David H.
    Kobashigawa, Jon A.
    CURRENT OPINION IN CARDIOLOGY, 2017, 32 (03) : 301 - 307
  • [8] Pharmaceutical Costs of Desensitization Therapy in Patients Awaiting Lung Transplantation in France
    Annaë Liu
    Mélisande Bernard
    BioDrugs, 2014, 28 : 55 - 61
  • [9] Pharmaceutical Costs of Desensitization Therapy in Patients Awaiting Lung Transplantation in France
    Liu, Annae
    Bernard, Melisande
    BIODRUGS, 2014, 28 (01) : 55 - 61
  • [10] HLA Desensitization in Pediatric Heart Transplant Candidates: Efficacy of Rituximab and IVIg
    Schumacher, K. R.
    Schauss, D.
    Schall, C. A.
    Kamoun, M.
    Ramon, D.
    Zamberlan, M. C. G.
    Gajarski, R. J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (04): : S168 - S168
12345